{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:56:43Z","timestamp":1787504203300,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the effectiveness of intraoperative vancomycin powder in prevention of surgical site infection and biofilm formation on implants in a contaminated animal fixation model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We created a rabbit surgical model including fixation implants at a tibial surgical site seeded with methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      . Our study cohort included 18 rabbits. Nine received vancomycin powder at the surgical site, and the other 9 did not. Serum vancomycin levels were measured at scheduled time points over 24 hours. Bone infection and implant biofilm formation were determined based on the number of colony-forming units present 2 weeks after surgery. Radiography, histology, and electron microscopy aided in evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      No bone infection or implant colonization occurred in the vancomycin powder group. Six bone infections and 6 implant biofilm formations (67%; 95% confidence interval, 45%\u201388%) occurred in the group that did not receive vancomycin powder (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009). Serum vancomycin levels were detectable at minimal levels at 1 and 6 hours only. Pathological changes occurred in the specimens that were positive for infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Intraoperative vancomycin powder application at the time of fixation decreases risk for bone infection and biofilm formation on implants in a rabbit model, with minimal increase in serum vancomycin levels. The results are encouraging and support the rationale for a clinical trial investigating the use of local vancomycin powder to reduce the rate of surgical site infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance:<\/jats:title>\n                    <jats:p>Infection is a common complication of surgery, especially with implants. Simple methods to prevent or decrease the occurrence of infection would benefit the patient and the health care system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000001136","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T11:42:42Z","timestamp":1517571762000},"page":"263-268","source":"Crossref","is-referenced-by-count":21,"title":["Intraoperative Vancomycin Powder Reduces Staphylococcus aureus Surgical Site Infections and Biofilm Formation on Fixation Implants in a Rabbit Model"],"prefix":"10.1097","volume":"32","author":[{"given":"James Paul","family":"Hovis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Montalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrius","family":"Marinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Shirtliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore T.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.spinee.2015.01.030","article-title":"Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review","volume":"15","author":"Kang","year":"2015","journal-title":"Spine J."},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.spinee.2013.10.012","article-title":"Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis","volume":"14","author":"Chiang","year":"2014","journal-title":"Spine J."},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ajic.2009.10.001","article-title":"National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009","volume":"37","author":"Edwards","year":"2009","journal-title":"Am J Infect Control."},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00423-011-0772-0","article-title":"Surgical site infections: economic consequences for the health care system","volume":"396","author":"Graf","year":"2011","journal-title":"Langenbecks Arch Surg."},{"key":"R5-20230828","first-page":"32816","article-title":"Department of Health and Human Services Medicaid Program: payment adjustment for provider-preventable conditions including health care-acquired conditions\u2014final rule","volume":"76","year":"2011","journal-title":"Fed Regist."},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/1071100715586567","article-title":"Topically applied vancomycin powder reduces the rate of surgical site infection in diabetic patients undergoing foot and ankle surgery","volume":"36","author":"Wukich","year":"2015","journal-title":"Foot Ankle Int."},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10195-015-0352-0","article-title":"Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study","volume":"16","author":"Singh","year":"2015","journal-title":"J Orthop Traumatol."},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/BOT.0000000000000617","article-title":"Time-dependent effectiveness of locally applied vancomycin powder in a contaminated traumatic orthopaedic wound model","volume":"30","author":"Tennent","year":"2016","journal-title":"J Orthop Trauma."},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.arth.2014.02.012","article-title":"Establishing a role for vancomycin powder application for prosthetic joint infection prevention: results of a wear simulation study","volume":"29","author":"Qadir","year":"2014","journal-title":"J Arthroplasty."},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/IAI.00392-06","article-title":"Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection","volume":"74","author":"Brady","year":"2006","journal-title":"Infect Immun."},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"e00037","DOI":"10.1128\/genomeA.00037-12","article-title":"Draft genome sequence of the methicillin-resistant Staphylococcus aureus isolate MRSA-M2","volume":"1","author":"Harro","year":"2013","journal-title":"Genome Announc."},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.50.4.1463-1469.2006","article-title":"Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility","volume":"50","author":"Jabra-Rizk","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/IAI.70.11.6339-6345.2002","article-title":"Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms","volume":"70","author":"Leid","year":"2002","journal-title":"Infect Immun."},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1574-695X.2010.00710.x","article-title":"Microbial interactions and differential protein expression in Staphylococcus aureus: Candida albicans dual-species biofilms","volume":"59","author":"Peters","year":"2010","journal-title":"FEMS Immunol Med Microbiol."},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/IAI.01386-10","article-title":"Murine immune response to a chronic Staphylococcus aureus biofilm infection","volume":"79","author":"Prabhakara","year":"2011","journal-title":"Infect Immun."},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1128\/IAI.05571-11","article-title":"Suppression of the inflammatory immune response prevents the development of chronic biofilm infection due to methicillin-resistant","volume":"79","author":"Prabhakara","year":"2011","journal-title":"Staphylococcus Aureus Infect Immun."},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00003086-200208000-00027","article-title":"Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite","volume":"401","author":"Shirtliff","year":"2002","journal-title":"Clin Orthop Relat Res."},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.46.1.231-233.2002","article-title":"Gatifloxacin efficacy in treatment of experimental methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits","volume":"46","author":"Shirtliff","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/48.2.253","article-title":"Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits","volume":"48","author":"Shirtliff","year":"2001","journal-title":"J Antimicrob Chemother."},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00003086-199902000-00026","article-title":"Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits","volume":"359","author":"Shirtliff","year":"1999","journal-title":"Clin Orthop Relat Res."},{"key":"R21-20230828","article-title":"Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens","author":"Shirtliff","year":"2012"},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/AAC.13.1.30","article-title":"Sensitive bioassay for vancomycin","volume":"13","author":"Walker","year":"1978","journal-title":"Antimicrob Agents Chemother."},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.spinee.2011.04.025","article-title":"Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder","volume":"11","author":"O'Neill","year":"2011","journal-title":"Spine J."},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","article-title":"Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes","volume":"36","author":"Sweet","year":"2011","journal-title":"Spine (Phila Pa 1976)."},{"issue":"suppl 4","key":"R26-20230828","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1007\/s00586-011-2104-z","article-title":"Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period","volume":"21","author":"Molinari","year":"2012","journal-title":"Eur Spine J."},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2106\/JBJS.K.00756","article-title":"Methods to decrease postoperative infections following posterior cervical spine surgery","volume":"95","author":"Pahys","year":"2013","journal-title":"J Bone Joint Surg Am."},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.wneu.2014.12.033","article-title":"The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence","volume":"83","author":"Bakhsheshian","year":"2015","journal-title":"World Neurosurg."},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3928\/01477447-20130122-10","article-title":"Vancomycin prophylaxis of surgical site infection in clean orthopedic surgery","volume":"36","author":"Kanj","year":"2013","journal-title":"Orthopedics."},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.med.59.110106.132000","article-title":"Bacterial and fungal biofilm infections","volume":"59","author":"Lynch","year":"2008","journal-title":"Annu Rev Med."},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/146.4.487","article-title":"Pathogenesis of foreign body infection: description and characteristics of an animal model","volume":"146","author":"Zimmerli","year":"1982","journal-title":"J Infect Dis."},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases society of America, the American society of health-system pharmacists, and the society of infectious diseases pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005131-201805000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:12:39Z","timestamp":1693188759000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005131-201805000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000001136","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}